PrimeRFP SCOUT · Federal Contract Recompete Brief

36C25726N0007NTX FECAL OCCULT BLOOD testing CPRR — Polymedco Cancer Diagnostic Products LLC

Polymedco Cancer Diagnostic Products LLC holds $13.0M across 407 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent 36C25724D0008. Recompete timing centers on the Sep 30, 2026 PoP end — agencies typically plan 12–18 months ahead.

257-Network Contract Office 17 (36C257)

Awarding office

Polymedco Cancer Diagnostic Products LLC

Recipient

Sep 30, 2026

PoP end

$165K

Obligated

$165K

Potential

325413

NAICS

6550

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C25726N0007

Also listed as36C257-26-N-0007

Also listed as36C25724D0008-36C25726N0007

Agency257-Network Contract Office 17 (36C257)

Awarding office257-Network Contract Office 17 (36C257)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentPolymedco Cancer Diagnostic Products LLC

CAGE6U4P6

UEIJYKKQ1NLJRX7

NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550

Parent IDIQ / IDV36C25724D0008

Place of performanceCORTLANDT MANOR NY

Pricing typeFirm Fixed Price

Extent competedCompeted Under SAP

PoP startOct 1, 2025

PoP end (current)Sep 30, 2026

Obligated$165K

Current value$165K

Potential value$165K

NTX FECAL OCCULT BLOOD TESTING CPRR is a federal award for 257-Network Contract Office 17 (36C257) held by Polymedco Cancer Diagnostic Products LLC. Estimated value $165K ($165K obligated). Current period of performance ends Sep 30, 2026. Place of performance: CORTLANDT MANOR NY.

Recompete timing

Public

● Expiring in 3 days

Current PoP ends Sep 30, 2026 (3 days remaining). Agencies typically plan 12–18 months ahead — at 0.1 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 36C25726N0007? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Polymedco Cancer Diagnostic Products LLC — $13.0M obligated across 407 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($13.0M) · all agencies · Top 3 shown (50%); remaining ~50% is other agencies.

Department of Veterans Affairs (VA)$5.8M · 45%Department of Defense (DOD)$546K · 4%Department of Health and Human Services (HHS)$143K · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C24E22F0001

FOBT ANALYZER & SUPPLIES

$504K

Sep 30, 2026

36C25726N0140

VISN 17 FECAL IMMUNOCHEMICAL TEST (FIT) KIT MAILING SERVICE - ORDERING PERIOD 2

$615K

Jan 14, 2027

36C24826N0438

CANCER SCREENING

$440K

Mar 31, 2027

36C24826N0256

IFOBT REAGENTS

$133K

May 12, 2027

36C24426N0755

MAILED FIT PROGRAM: PATIENT NAVIGATION SERVICES

$368K

Jun 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C25726N0007?

36C25726N0007 (NTX FECAL OCCULT BLOOD testing CPRR) is a 257-Network Contract Office 17 (36C257) award with a potential value of $165K, currently held by Polymedco Cancer Diagnostic Products LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C257-26-N-0007?

36C257-26-N-0007 is the dashed form of PIID 36C25726N0007 (NTX FECAL OCCULT BLOOD testing CPRR), held by Polymedco Cancer Diagnostic Products LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C25726N0007?

257-Network Contract Office 17 (36C257) awarded 36C25726N0007 to Polymedco Cancer Diagnostic Products LLC (potential $165K).

Who is the incumbent on 36C25726N0007?

Polymedco Cancer Diagnostic Products LLC is the incumbent with $13.0M across 407 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Polymedco Cancer Diagnostic Products LLC’s 36C25726N0007 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C25726N0007? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 24, 2026 · refreshed monthlyLatest procurement action Oct 1, 2025